Literature DB >> 18200440

Clinical and molecular genetics of acromegaly: MEN1, Carney complex, McCune-Albright syndrome, familial acromegaly and genetic defects in sporadic tumors.

Anelia Horvath1, Constantine A Stratakis.   

Abstract

Pituitary tumors are among the most common neoplasms in man; they account for approximately 15% of all primary intracranial lesions (Jagannathan et al., Neurosurg Focus, 19:E4, 2005). Although almost never malignant and rarely clinically expressed, pituitary tumors may cause significant morbidity in affected patients. First, given the critical location of the gland, large tumors may lead to mass effects, and, second, proliferation of hormone-secreting pituitary cells leads to endocrine syndromes. Acromegaly results from oversecretion of growth hormone (GH) by the proliferating somatotrophs. Despite the significant efforts made over the last decade, still little is known about the genetic causes of common pituitary tumors and even less is applied from this knowledge therapeutically. In this review, we present an update on the genetic syndromes associated with pituitary adenomas and discuss the related genetic defects. We next review findings on sporadic, non-genetic, pituitary tumors with an emphasis on pathways and animal models of pituitary disease. In conclusion, we attempt to present an overall, integrative approach to the human molecular genetics of both familiar and sporadic pituitary tumors.

Entities:  

Mesh:

Year:  2008        PMID: 18200440     DOI: 10.1007/s11154-007-9066-9

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  113 in total

1.  A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus.

Authors:  S C Guru; S K Agarwal; P Manickam; S E Olufemi; J S Crabtree; J M Weisemann; M B Kester; Y S Kim; Y Wang; M R Emmert-Buck; L A Liotta; A M Spiegel; M S Boguski; B A Roe; F S Collins; S J Marx; L Burns; S C Chandrasekharappa
Journal:  Genome Res       Date:  1997-07       Impact factor: 9.043

2.  Pegvisomant for the treatment of gsp-mediated growth hormone excess in patients with McCune-Albright syndrome.

Authors:  Sunday O Akintoye; Marilyn H Kelly; Beth Brillante; Natasha Cherman; Sarah Turner; John A Butman; Pamela G Robey; Michael T Collins
Journal:  J Clin Endocrinol Metab       Date:  2006-05-23       Impact factor: 5.958

3.  PRKAR1A Mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex.

Authors:  Audrey Robinson-White; Elise Meoli; Sotirios Stergiopoulos; Anelia Horvath; Sosipatros Boikos; Ioannis Bossis; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2006-03-28       Impact factor: 5.958

4.  Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras.

Authors:  C M Pfarr; F Mechta; G Spyrou; D Lallemand; S Carillo; M Yaniv
Journal:  Cell       Date:  1994-02-25       Impact factor: 41.582

5.  Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11.

Authors:  R V Thakker; P Bouloux; C Wooding; K Chotai; P M Broad; N K Spurr; G M Besser; J L O'Riordan
Journal:  N Engl J Med       Date:  1989-07-27       Impact factor: 91.245

6.  Common genetic changes in hereditary and sporadic pituitary adenomas detected by comparative genomic hybridization.

Authors:  Svetlana D Pack; Liu-Xiu Qin; Evgenia Pak; Yun Wang; David O Ault; Poonam Mannan; Sivakumar Jaikumar; Constantine A Stratakis; Edward H Oldfield; Zhengping Zhuang; Robert J Weil
Journal:  Genes Chromosomes Cancer       Date:  2005-05       Impact factor: 5.006

7.  Normal vision despite narrowing of the optic canal in fibrous dysplasia.

Authors:  Janice S Lee; Edmond FitzGibbon; John A Butman; Craig R Dufresne; Harvey Kushner; Shlomo Wientroub; Pamela G Robey; Michael T Collins
Journal:  N Engl J Med       Date:  2002-11-21       Impact factor: 91.245

8.  Transforming DNA sequences present in human prolactin-secreting pituitary tumors.

Authors:  R Gonsky; V Herman; S Melmed; J Fagin
Journal:  Mol Endocrinol       Date:  1991-11

9.  A pleiomorphic GH pituitary adenoma from a Carney complex patient displays universal allelic loss at the protein kinase A regulatory subunit 1A (PRKARIA) locus.

Authors:  I Bossis; A Voutetakis; L Matyakhina; S Pack; M Abu-Asab; I Bourdeau; K J Griffin; N Courcoutsakis; S Stergiopoulos; D Batista; M Tsokos; C A Stratakis
Journal:  J Med Genet       Date:  2004-08       Impact factor: 6.318

Review 10.  Pathology and molecular genetics of the pituitary gland in patients with the 'complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas' (Carney complex).

Authors:  Constantine A Stratakis; Ludmila Matyakhina; Nickolas Courkoutsakis; Nickolas Patronas; Antonios Voutetakis; Sotirios Stergiopoulos; Ioannis Bossis; J Aidan Carney
Journal:  Front Horm Res       Date:  2004       Impact factor: 2.606

View more
  17 in total

Review 1.  Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics.

Authors:  Paraskevi Salpea; Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2013-09-05       Impact factor: 4.102

Review 2.  Familial pituitary tumor syndromes.

Authors:  Marianne S Elston; Kerrie L McDonald; Roderick J Clifton-Bligh; Bruce G Robinson
Journal:  Nat Rev Endocrinol       Date:  2009-06-30       Impact factor: 43.330

3.  A giant? Think of genetics: growth hormone-producing adenomas in the young are almost always the result of genetic defects.

Authors:  Constantine A Stratakis
Journal:  Endocrine       Date:  2015-06-09       Impact factor: 3.633

4.  mTOR is frequently active in GH-secreting pituitary adenomas without influencing their morphopathological features.

Authors:  Emir Ahmed Sajjad; Grzegorz Zieliński; Maria Maksymowicz; Łukasz Hutnik; Tomasz Bednarczuk; Paweł Włodarski
Journal:  Endocr Pathol       Date:  2013-03       Impact factor: 3.943

5.  Is Routine Screening of Young Asymptomatic MEN1 Patients Necessary?

Authors:  Jerena Manoharan; Friedhelm Raue; Caroline L Lopez; Max B Albers; Carmen Bollmann; Volker Fendrich; Emily P Slater; Detlef K Bartsch
Journal:  World J Surg       Date:  2017-08       Impact factor: 3.352

Review 6.  Acrodysostosis syndromes.

Authors:  C Silve; C Le-Stunff; E Motte; Y Gunes; A Linglart; E Clauser
Journal:  Bonekey Rep       Date:  2012-11-21

7.  An Intronic mutation is associated with prolactinoma in a young boy, decreased penetrance in his large family, and variable effects on MEN1 mRNA and protein.

Authors:  L Drori-Herishanu; A Horvath; M Nesterova; Y Patronas; M Lodish; E Bimpaki; N Patronas; S Agarwal; R Salvatori; M Martari; V Mericq; C A Stratakis
Journal:  Horm Metab Res       Date:  2009-04-23       Impact factor: 2.936

Review 8.  Pituitary tumors in childhood: update of diagnosis, treatment and molecular genetics.

Authors:  Margaret F Keil; Constantine A Stratakis
Journal:  Expert Rev Neurother       Date:  2008-04       Impact factor: 4.618

9.  Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.

Authors:  Raul M Luque; Beatriz S Soares; Xiao-ding Peng; Sonia Krishnan; Jose Cordoba-Chacon; Lawrence A Frohman; Rhonda D Kineman
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

Review 10.  Pituitary gland and beta-catenin signaling: from ontogeny to oncogenesis.

Authors:  Maria Gueorguiev; Ashley B Grossman
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.